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Abstract
Coronavirus disease 2019 (COVID-19) is a pandemic. Neurological complications of COVID-19
have not been reported. Encephalopathy has not been described as a presenting symptom or
complication of COVID-19. We report a case of a 74-year-old patient who traveled from Europe
to the United States and presented with encephalopathy and COVID-19.
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Introduction
Coronavirus disease (COVID-19) was first detected in December 2019 in China and has rapidly
spread to the rest of world. The World Health Organization (WHO) has recently declared
COVID-19 a pandemic, with more than 180,000 reported cases to date. COVID-19 is a novel
corona virus that probably emerged from an animal source, which is now spreading rapidly
from person to person. The typical symptoms of COVID-19 can range from mild to severe
respiratory illness. The most common symptoms that have been reported thus far are fever,
cough, and shortness of breath. The elderly population, especially those with underlying
medical problems like chronic bronchitis, emphysema, heart failure, or diabetes, are more likely
to develop serious illness [1,2].
Neurological complications in COVID-19 infected patients have not been widely reported.
Since elderly patients with chronic medical conditions are at an increased risk of altered mental
status in the setting of acute infections, patients with COVID-19 infection can also present
with acute encephalopathy and changes in their level of consciousness. Here we report a case
of a patient who presented with encephalopathy and was found to be infected with COVID-19.
Case Presentation
A 74-year-old male with past medical history of atrial fibrillation, cardioembolic stroke,
parkinson disease, chronic obstructive pulmonary disease (COPD), and recent cellulitis
presented to the emergency department with a chief complaint of fever and cough. The patient
had a full workup, including routine labs and chest x-ray, which were nonrevealing. The patient
was discharged home under the suspicion that this was an exacerbation of his COPD. The
patient went home on oral antibiotics. The patient returned to the emergency room (ER) within
24 hours with worsening symptoms, including headache, altered mental status, fever, and
cough. The patient is originally from the Netherlands and presented to our hospital seven days
after arriving to the United States. The patient was admitted to the hospital for further workup.
All protective measures and precautions for suspected COVID-19 infection were taken. The
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patient was placed in isolation. Repeat chest x-ray demonstrated small right pleural effusion
with bilateral ground glass opacities (see Figure 1). CT chest revealed patchy bibasilar
consolidations and subpleural opacities. Both throat sputum and nasopharyngeal cultures were
negative for strep. Blood cultures were negative, and urine analysis was negative. Influenza A
and B tests were negative.
FIGURE 1: Chest X-ray shows multifocal airspace opacities and
“ground-glass opacities”, characteristic signs of COVID-19
infection.
Due to the severe alteration in mental status, neurology was consulted. Upon examination, the
patient was found encephalopathic, nonverbal, and unable to follow any commands; however,
he was able to move all his extremities and was reacting to noxious stimuli. No nuchal rigidity
was noted. A CT scan of the head and EEG were ordered immediately. The CT scan of the head
showed no acute abnormalities. There was the presence of an area of encephalomalacia in the
left temporal region, consistent with the prior history of embolic stroke (see Figure 2). The EEG
showed bilateral slowing and focal slowing in the left temporal region with sharply countered
waves (see Figure 3).
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FIGURE 2: CT scan of the head that shows no acute changes.
There is an area of hypodensity in the right temporal region,
consistent with patient know prior history of left PCA embolic
stroke
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FIGURE 3: EEG shows diffuse slowing and focal slowing
sharply contoured waves in the left temporal region. These
findings are consistent with an encephalopathy, focal left
temporal lobe dysfunction, and possible epileptogenicity.
The patient was started on antiepileptic medication prophylactically given the possibility of
subclinical seizures in this patient with an area of encephalomalacia and epileptiform
discharges in the right temporal region. The patient was treated empirically with vancomycin,
meropenem, and acyclovir. A lumbar puncture did not reveal any evidence of central nervous
system infection (see Table 1). Due to his progression in symptomatology, he was then tested
for COVID-19 and found to be positive. The patient developed respiratory failure and required
intubation and was transferred to the ICU. Based on anecdotal experience from other medical
centers, the patient was started on hydroxychloroquine and lopinavir/ritonavir, and was
continued on broad-spectrum antibiotics. The patient currently remains in the ICU, critically ill
with poor prognosis. 
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CSF studies  
Appearance Clear
Color None
White blood cells 4
Red blood cells 0
CSF glucose 75
CSF protein 68
Albumin 36
HSV PCR Not detected
CMV PCR Negative
Respiratory syncytial virus Negative
  
TABLE 1: CSF analysis: CSF studies show no evidence of CNS infection.
CMV, cytomegalovirus; CNS, central nervous system; CSF, cerebrospinal fluid; HSV, herpes simplex virus; PCR, polymerase chain
reaction
Discussion
COVID-19 is a pandemic than ranges from mild disease with nonspecific signs and symptoms
to acute respiratory symptoms to severe pneumonia with respiratory failure and septic shock.
Current evidence suggests that COVID-19 patients commonly had neurological symptoms
manifested as acute stroke (6%), consciousness impairment (15%), and skeletal muscle injury
(19%) [3]. Elderly patients with chronic conditions are at an increased risk of altered mental
status in the setting of acute infections. Since COVID-19 affects more the elderly and those
with preexisting conditions, patients with prior neurological conditions and acute respiratory
symptoms are at an increased risk of encephalopathy on initial presentation. The cerebrospinal
fluid studies in our patient were normal; therefore, COVID-19 does not cross the blood-brain
barrier and does not cause meningitis or encephalitis. Our case highlights the importance of
identifying encephalopathy as a presenting sign of COVID-19. Patients with COVID-19 testing
positive with common features of cough, fever, and shortness of breath can present to the ER
with encephalopathy, or can develop encephalopathy during their hospital stay. Neurologist
will be consulted, and practitioners have to know that this may encounter in the acute setting.
Given that there is limited data on neurological symptoms, health care providers benefit from
accurate and real-life data to better treat their patients. If patients with neurological conditions
are not considered to have COVID-19, this may present a nationwide issue to health care team
members treating patients and in turn the general public if they are discharged and further
exposed to other people.
Conclusions
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Health care providers should be aware that patients with COVID-19 can present with
encephalopathy in the acute setting and during hospitalization. 
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